![Kuno Sommer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kuno Sommer
Presidente presso
BACHEM HOLDING AG
Patrimonio netto: 4 M $ in data 31/07/2026
Profilo
Kuno Sommer è presidente di Targimmune Therapeutics AG, presidente del consiglio di sorveglianza di Sunstar-Holding AG, presidente di Polyphor AG, presidente di Bachem Holding AG, presidente di PDS Pathology Data Systems Co. Ag, un presidente di Kenta Biotech AG e un presidente di Bachem Americas, Inc. Fa parte del consiglio di amministrazione di Ferienclub Privilge AG. Il Dr. Sommer è stato precedentemente impiegato come amministratore delegato di Harlan Laboratories Ltd., amministratore delegato di Berna Biotech AG, amministratore delegato di Givaudan SA, direttore di F. Hoffmann-La Roche Ltd., amministratore delegato di Crucell NV, responsabile della ricerca contrattuale di Harlan Laboratories Ltd., presidente di Pevion Biotech AG e membro del comitato esecutivo di Roche Holding AG. Ha ricevuto il suo MBA dall'Università di Basilea e un dottorato dall'Università di Basilea.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2025 | 48.000 ( 0,06% ) | 4 M $ | 31/07/2026 |
Ultime notizie su Kuno Sommer
Posizioni attive di Kuno Sommer
| Società | Posizione | Inizio |
|---|---|---|
| BACHEM HOLDING AG | Presidente | 25/04/2012 |
| SPEXIS AG | Direttore/Membro del Consiglio | 30/12/2021 |
PDS Pathology Data Systems Co. Ag | Presidente | 01/01/2012 |
Data Systems AG | Presidente | - |
Bachem Americas, Inc.
 Bachem Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Presidente | - |
Ferienclub Privilège AG | Direttore/Membro del Consiglio | - |
Targimmune Therapeutics AG
 Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies | Presidente | 01/11/2017 |
Sunstar-Holding AG
 Sunstar-Holding AG Hotels/Resorts/Cruise linesConsumer Services Operates hotels | Presidente | 28/09/2016 |
Kenta Biotech AG
 Kenta Biotech AG BiotechnologyHealth Technology Engages in the research, development, production, and marketing of biotechnological and pharmaceutical products | Presidente | 01/01/2006 |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Precedenti posizioni note di Kuno Sommer
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | - |
Formazione di Kuno Sommer
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
72
Relazioni di 1° grado
18
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 18 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Develops, produces and markets vaccines, proteins and antibodies | Health Technology |
Givaudan SA
 Givaudan SA Household/Personal CareConsumer Non-Durables Manufactures and distributes fragrance, flavor & beauty products | Consumer Non-Durables |
Berna Biotech AG
 Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Produces and develops immunobiological preparations | Commercial Services |
Bachem Holding AG
 Bachem Holding AG Pharmaceuticals: MajorHealth Technology Operates as an independent, technology-based, public biochemical company | Health Technology |
Sunstar-Holding AG
Sunstar-Holding AG Hotels/Resorts/Cruise linesConsumer Services Operates hotels | Consumer Services |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spexis Ltd.
 Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
Pevion Biotech AG
 Pevion Biotech AG Pharmaceuticals: MajorHealth Technology Develops efficient and safe vaccines based on proprietary technology | Health Technology |
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Engages in the research, development, production, and marketing of biotechnological and pharmaceutical products | Health Technology |
Bachem Americas, Inc.
Bachem Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Harlan Laboratories Ltd.
 Harlan Laboratories Ltd. Miscellaneous Commercial ServicesCommercial Services Provides non-clinical contract research, research models and animal diets services to pharmaceutical, biotech, medical device, agrochemical and chemical industry | Commercial Services |
Ferienclub Privilège AG | |
Infors AG
 Infors AG Medical SpecialtiesHealth Technology Manufactures bioreactors, incubation shakers and provides bioprocess software | Health Technology |
PDS Pathology Data Systems Co. Ag | |
Targimmune Therapeutics AG
Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies | Health Technology |
Data Systems AG |
